(Q42383824)

28 October 2017

0 references

LHRH analogues in breast cancer: clever, but do we need them? (English)

1 reference

28 October 2017

Smith IE

1

1 reference

PMC publication ID

1971625

28 October 2017

language of work or name

English

0 references

publication date

1 January 1991

1 reference

28 October 2017

2

1 reference

British Journal of Cancer

inferred from page(s)

published in

1 reference

28 October 2017

63

1 reference

28 October 2017

1

1 reference

28 October 2017

15-16

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1991.6

28 October 2017

0 references

cites work

Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971625

Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971625

The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971625

Zoladex: endocrine and therapeutic effects in post-menopausal breast cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971625

Use of luteinising hormone-releasing hormone agonist (leuprorelin) in advanced post-menopausal breast cancer: clinical and endocrine effects

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971625

Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971625

Anti-tumour activity of ICI 118630, a new potent luteinizing hormone-releasing hormone agonist

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971625

Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist

28 May 2018

1 reference

12 December 2020

The treatment of postmenopausal women with advanced breast cancer with buserelin

1 reference

12 December 2020

Medical castration produced by the GnRH analogue leuprolide to treat metastatic breast cancer

1 reference

12 December 2020

Gonadotropin-releasing hormone binding sites in human breast carcinoma

1 reference

12 December 2020

A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer

1 reference

12 December 2020

Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group

1 reference

12 December 2020

Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme

1 reference

12 December 2020

Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatments

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1991.6

1 reference

28 October 2017

1 reference

PMC publication ID

1971625

28 October 2017

PubMed publication ID

1989655

1 reference

PMC publication ID

1971625